2020
DOI: 10.1002/ptr.6917
|View full text |Cite
|
Sign up to set email alerts
|

A systematic review on phytochemicals for the treatment of dengue

Abstract: Dengue fever is prevalent in subtopic regions, producing mortality and morbidity worldwide, which have been of major concern to different governments and World Health Organization. The search of new anti‐dengue agents from phytochemicals was assumed to be highly emergent in past. The phytochemicals have been used in wide distribution of vector ailments such as malaria. The demand of the phytochemicals is based on the medicines which are mostly considered to be safer, less harmful than synthetic drugs and nonto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 16 publications
(11 citation statements)
references
References 163 publications
0
10
0
Order By: Relevance
“…9,10 According to several studies, recovery from DENV infection is associated with permanent immunity against that serotype, whereas infection with different serotypes results in only transitory and partial protection, increasing the risk of severe dengue. 11 Indicators of dengue fever are similar to those of the common cold and influenza; that is why people get confused with the treatment of dengue. It can damage the liver by increasing the liver enzymes.…”
mentioning
confidence: 99%
“…9,10 According to several studies, recovery from DENV infection is associated with permanent immunity against that serotype, whereas infection with different serotypes results in only transitory and partial protection, increasing the risk of severe dengue. 11 Indicators of dengue fever are similar to those of the common cold and influenza; that is why people get confused with the treatment of dengue. It can damage the liver by increasing the liver enzymes.…”
mentioning
confidence: 99%
“…With no commercial antivirals available for public use against the Dengue virus and severe Dengue infections leading to conditions such DHF and DSS, the discovery of potential anti-DENV agents is still a pressing issue. Drugs used to treat other conditions, such as the anti-pyretic drug Acetaminophen and the anti-hepatitic Sofosbuvir, were also shown to reduce the Dengue infection symptoms to some extent [ 121 , 122 ]. The vaccine Dengvaxia which was given the license for use in about 20 countries recently began to show some complications in seronegative patients [ 123 ].…”
Section: Antivirals Against Dengue Infectionmentioning
confidence: 99%
“…Herein lays the promise of natural compounds. With their anticipated minimal side effects, widespread availability, and potential efficacy, natural compounds emerge as beacons of hope, particularly for economically challenged nations [ 4 ]. Numerous studies have unveiled the antiviral prowess of various phytonutrients against pathogens such as the dengue virus (DENV) and chikungunya virus (CHIKV).…”
Section: Introductionmentioning
confidence: 99%
“…Numerous studies have unveiled the antiviral prowess of various phytonutrients against pathogens such as the dengue virus (DENV) and chikungunya virus (CHIKV). Among these bioactive compounds are polysaccharides, alkaloids, terpenoids, terpenes, and flavonoids [ 4 ]. Interestingly, medicinal plants have showcased superior anti-DENV and CHIKV activity when compared to their synthetic counterparts [ 5 ].…”
Section: Introductionmentioning
confidence: 99%